High proportion of multidrug-resistant organisms in children hospitalized abroad
Kazuhiro Uda1, Takanori Funaki1, Kensuke Shoji1
1Division of Infectious Diseases, Department of Medical Subspecialties, National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan.
Abstract:
Our infection control team initiated active screening for multidrug-resistant organisms (MDROs) among children who had been hospitalized abroad before their admission to our hospital. MDROs were detected in 19 of 34 cases (56%), including 3 isolates of Enterobacteriaceae harboring carbapenemase genes still rare in Japan. Early recognition of MDROs by screening this population may be required to avoid the introduction of new modes of resistance into the hospital environment.
Insights
Active screening for multidrug-resistant organisms (MDROs) in children hospitalized abroad detected high rates of MDROs, including rare carbapenemase-producing Enterobacteriaceae. Early detection is crucial to prevent hospital introduction of new resistance.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Hospital-acquired infections pose a significant threat to patient safety.
- Multidrug-resistant organisms (MDROs) are a growing global health concern.
- International travel can facilitate the spread of infectious diseases and resistant organisms.
Purpose of the Study:
- To assess the prevalence of MDROs in children hospitalized abroad before admission to a Japanese hospital.
- To identify specific MDROs and resistance mechanisms, particularly those rare in Japan.
- To evaluate the effectiveness of active screening for preventing MDRO introduction into the hospital.
Main Methods:
- Prospective screening of pediatric patients with a history of hospitalization abroad.
- Microbiological culture and susceptibility testing for MDRO detection.
- Molecular methods for identifying carbapenemase genes in Enterobacteriaceae isolates.
Main Results:
- MDROs were detected in 19 out of 34 screened children (56%).
- Three isolates of carbapenemase-gene-harboring Enterobacteriaceae were identified, a finding rare in Japan.
- Screening identified a substantial burden of MDROs in this high-risk population.
Conclusions:
- Active screening of children with prior international hospitalization is essential for early MDRO detection.
- This strategy can help prevent the introduction of novel resistance mechanisms, such as carbapenemase-producing Enterobacteriaceae, into the hospital.
- Implementing targeted surveillance is critical for maintaining hospital infection control and combating antimicrobial resistance.
Related Concept Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Sample Proportion and Population Proportion
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
09:57Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Hospitals-II
Nurses that work in...
Hospitals-I


